Non-bacterial thrombotic endocarditis historical perspective: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Aisha Adigun (talk | contribs) |
||
| Line 8: | Line 8: | ||
===Discovery=== | ===Discovery=== | ||
* | *The association between [[thromboembotic events]] and [[malignancy]] was made by Armand Trousseau in the year 1865.<ref>Trousseau A. Clinique médicale de l’Hôtel-Dieu de Paris. Paris: Ballière; 1865 </ref> | ||
*[[Non-bacterial thrombotic endocarditis]] (NBTE) was first discovered by Zeigler,<ref name="pmid3548296">{{cite journal |vauthors=Lopez JA, Ross RS, Fishbein MC, Siegel RJ |title=Nonbacterial thrombotic endocarditis: a review |journal=Am. Heart J. |volume=113 |issue=3 |pages=773–84 |date=March 1987 |pmid=3548296 |doi=10.1016/0002-8703(87)90719-8 |url=}}</ref> in 1888 following his identification of [[vegetation]] in cardiac valves associated with [[inflammatory states]]. | |||
*[ | *In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman<ref>E Ziegler - Ver Kong Inn Med, 1888 - ci.nii.ac.jp </ref> published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis". | ||
*In 1936, The name non-bacterial thrombotic endocarditis was coined by Gross and Friedberg. <ref> GROSS L, FRIEDBERG CK. NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION. Arch Intern Med (Chic). 1936;58(4):620–640. doi:10.1001/archinte.1936.00170140045004 </ref>. They postulated that the attachment of [[fibrin]] to [[cardiac valves]] is the cause of non-bacterial thrombotic endocarditis. | |||
*The | *In recent years it has been suggested that NBTE is a [[hypercoagulable state]] caused by a [[malignancy]] that leads to a surge in [[tumor necrosis factor]] and [[interleukin-1]], resulting in the formation of [[thrombi]].<ref> Schlittler LA, Dallagasperina VW, Schavinski C, Baggio AP, Lazaretti NS, Villaroel RU. Marantic endocarditis and adenocarcinoma of unknown primary site. Arq Bras Cardiol. 2011;96(4):e73–5 </ref> <br /> | ||
*In [ | |||
===Landmark Events in the Development of Treatment Strategies=== | ===Landmark Events in the Development of Treatment Strategies=== | ||
Revision as of 16:02, 10 July 2020
|
non-bacterial thrombotic endocarditis |
|
Differentiating non-bacterial thrombotic endocarditis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non-bacterial thrombotic endocarditis historical perspective On the Web |
|
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis historical perspective |
|
FDA on Non-bacterial thrombotic endocarditis historical perspective |
|
CDC on Non-bacterial thrombotic endocarditis historical perspective |
|
Non-bacterial thrombotic endocarditis historical perspective in the news |
|
Blogs on Non-bacterial thrombotic endocarditis historical perspective |
|
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
Historical Perspective
Discovery
- The association between thromboembotic events and malignancy was made by Armand Trousseau in the year 1865.[1]
- Non-bacterial thrombotic endocarditis (NBTE) was first discovered by Zeigler,[2] in 1888 following his identification of vegetation in cardiac valves associated with inflammatory states.
- In 1926, Dr. Benjamin Sacks and Dr. Emmanuel Libman[3] published cases of "valvular masses" that were examined clinically and during autopsies and found to be free of all microorganisms. These masses were initially named "indeterminate endocarditis".
- In 1936, The name non-bacterial thrombotic endocarditis was coined by Gross and Friedberg. [4]. They postulated that the attachment of fibrin to cardiac valves is the cause of non-bacterial thrombotic endocarditis.
- In recent years it has been suggested that NBTE is a hypercoagulable state caused by a malignancy that leads to a surge in tumor necrosis factor and interleukin-1, resulting in the formation of thrombi.[5]
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
The following are a few famous cases of [disease name]:
References
- ↑ Trousseau A. Clinique médicale de l’Hôtel-Dieu de Paris. Paris: Ballière; 1865
- ↑ Lopez JA, Ross RS, Fishbein MC, Siegel RJ (March 1987). "Nonbacterial thrombotic endocarditis: a review". Am. Heart J. 113 (3): 773–84. doi:10.1016/0002-8703(87)90719-8. PMID 3548296.
- ↑ E Ziegler - Ver Kong Inn Med, 1888 - ci.nii.ac.jp
- ↑ GROSS L, FRIEDBERG CK. NONBACTERIAL THROMBOTIC ENDOCARDITIS: CLASSIFICATION AND GENERAL DESCRIPTION. Arch Intern Med (Chic). 1936;58(4):620–640. doi:10.1001/archinte.1936.00170140045004
- ↑ Schlittler LA, Dallagasperina VW, Schavinski C, Baggio AP, Lazaretti NS, Villaroel RU. Marantic endocarditis and adenocarcinoma of unknown primary site. Arq Bras Cardiol. 2011;96(4):e73–5